Search research articles
Contact Us
Filters
Showing results (91-100 of 156) with videos related to
Page
of 16
Sort By:
Blood
|
September 6, 2013
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)
Meletios A Dimopoulos, Ramón García-Sanz, Maria Gavriatopoulou, et al.
ACS Macro Letters
|
June 2, 2022
Measurement of Cohesion and Adhesion of Semiconducting Polymers by Scratch Testing: Effect of Side-Chain Length and Degree of Polymerization
Daniel Rodriquez, James G Kohl, Pierre Morel, et al.
Blood
|
November 23, 2016
BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years
Maria Gavriatopoulou, Ramón García-Sanz, Efstathios Kastritis, et al.
Ejhaem
|
March 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World Analysis
Thomas Hueso, Grégory Lazarian, Paul Chauvet, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 9, 2023
Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes
Angèle Coutant, Vincent Cockenpot, Lauriane Muller, et al.
British Journal of Haematology
|
November 3, 2021
Accurate classification of plasma cell dyscrasias is achieved by combining artificial intelligence and flow cytometry
Valentin Clichet, Véronique Harrivel, Caroline Delette, et al.
Blood Advances
|
May 7, 2021
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia
Cécile Tomowiak, Stéphanie Poulain, Charles Herbaux, et al.
Journal of Neural Engineering
|
December 9, 2015
Long-term decoding of movement force and direction with a wireless myoelectric implant
Pierre Morel, Enrico Ferrea, Bahareh Taghizadeh-Sarshouri, et al.
Blood
|
November 19, 2008
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia
Steven P Treon, Andrew R Branagan, Leukothea Ioakimidis, et al.
Blood
|
February 7, 2009
International prognostic scoring system for Waldenstrom macroglobulinemia
Pierre Morel, Alain Duhamel, Paolo Gobbi, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 156) with videos related to
Sort By:
Page
of 16
Blood
|
September 6, 2013
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)
Meletios A Dimopoulos, Ramón García-Sanz, Maria Gavriatopoulou, et al.
ACS Macro Letters
|
June 2, 2022
Measurement of Cohesion and Adhesion of Semiconducting Polymers by Scratch Testing: Effect of Side-Chain Length and Degree of Polymerization
Daniel Rodriquez, James G Kohl, Pierre Morel, et al.
Blood
|
November 23, 2016
BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years
Maria Gavriatopoulou, Ramón García-Sanz, Efstathios Kastritis, et al.
Ejhaem
|
March 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World Analysis
Thomas Hueso, Grégory Lazarian, Paul Chauvet, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 9, 2023
Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes
Angèle Coutant, Vincent Cockenpot, Lauriane Muller, et al.
British Journal of Haematology
|
November 3, 2021
Accurate classification of plasma cell dyscrasias is achieved by combining artificial intelligence and flow cytometry
Valentin Clichet, Véronique Harrivel, Caroline Delette, et al.
Blood Advances
|
May 7, 2021
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia
Cécile Tomowiak, Stéphanie Poulain, Charles Herbaux, et al.
Journal of Neural Engineering
|
December 9, 2015
Long-term decoding of movement force and direction with a wireless myoelectric implant
Pierre Morel, Enrico Ferrea, Bahareh Taghizadeh-Sarshouri, et al.
Blood
|
November 19, 2008
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia
Steven P Treon, Andrew R Branagan, Leukothea Ioakimidis, et al.
Blood
|
February 7, 2009
International prognostic scoring system for Waldenstrom macroglobulinemia
Pierre Morel, Alain Duhamel, Paolo Gobbi, et al.
Page
of 16